{"company":{"id":2198698,"name":"Insamo","domain":"insamo.com","url":"https://alion.io/company/insamo"},"section":"news","answer":"Insamo: 10 headlines on record, 0 headlines in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"10"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":1},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"kind":"Press release","title":"Check out our latest news","source":"businesswire.com","url":"https://businesswire.com/news/home/20240221132401/en/Insamo-Launches-with-12M-Funding-from-Playground-Global-venBio-and-MRL-Ventures-Fund-to-Develop-Best-in-Class-Membrane-Permeable-Macrocyclic-Peptides"}],"story":[{"title":"Launched Insamo launches to develop cyclic peptides · Chemical & Engineering News","url":"https://cen.acs.org/business/start-ups/Insamo-launches-develop-cyclic-peptides/102/i6"},{"title":"Raised a round Seed $12M · Pulse 2.0","url":"https://pulse2.com/insamo-raises-12-million-to-pioneer-the-discovery-of-membrane-permeable-and-orally-available-cyclic-peptides/"},{"title":"Raised a round Venture round $9.5M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1969222/000196922223000001/"},{"title":"Founded"}],"as_of":"2026-11-21","cite":"Insamo, News. Alion, Nov 21, 2026. https://alion.io/company/insamo/news","html_url":"https://alion.io/company/insamo/news","json_url":"https://alion.io/company/insamo/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-21T01:12:21Z"}}